Disclosures for "Monoaminergic Function and Anxiety, Depression, RBD, and Cognitive Impairment in Parkinson’s Disease"
-
Dr. Niemi has stock in GSK. Dr. Niemi has stock in Modulight. Dr. Niemi has stock in Orion Corporation. Dr. Niemi has stock in Physicians Realty Trust. Dr. Niemi has stock in Nightingale Health. Dr. Niemi has received research support from The Finnish Parkinson Foundation (Suomen Parkinson-saatio). Dr. Niemi has received research support from The Sigrid Juselius Foundation (Sigrid Juselius -saatio). Dr. Niemi has received research support from The Finnish Neurological Association (Suomen Neurologinen Yhdistys).
-
Valtteri Kaasinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nordic Infucare. Valtteri Kaasinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Valtteri Kaasinen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nordic Infucare. Valtteri Kaasinen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Valtteri Kaasinen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nordic Infucare.
-
The institution of Juho Joutsa has received research support from Finnish Medical Foundation. The institution of Juho Joutsa has received research support from Sigrid Juselius Foundation. The institution of Juho Joutsa has received research support from Instrumentarium Research Foundation. The institution of Juho Joutsa has received research support from Turku University Hospital.